Georgia M Davis, Michael S Hughes, Sue Brown, Judy Sibayan, M Citlalli Perez-Guzman, Meaghan Stumpf, Zachary Thompson, Marina Basina, Ronak Patel, Joi Hester, Amalia Abraham, Trang T Ly, Cherie Chaney, Marilyn Tan, Liana J Hsu, Craig Kollman, Roy W Beck, Rayhan Adi Lal, Bruce A Buckingham, Francisco Pasquel
Introduction Multiple daily injection (MDI) insulin therapy frequently fails to meet hospital glycemic goals and is prone to hypoglycemia. Automated insulin delivery (AID) with remote glucose monitoring offers a solution to these shortcomings. Research Design and Methods In a single-arm multicenter pilot trial, we tested the feasibility, safety, and effectiveness of the Omnipod 5 AID System with real-time continuous glucose monitoring (CGM) for up to 10 days in hospitalized patients with insulin-requiring requiring diabetes on non-ICU medical-surgical units...
August 14, 2023: Diabetes Technology & Therapeutics